Australia Hormone Replacement Therapy Market Size & Outlook
Australia hormone replacement therapy market, 2018-2030 (US$M)
Related Markets
Australia hormone replacement therapy market highlights
- The Australia hormone replacement therapy market generated a revenue of USD 376.2 million in 2022 and is expected to reach USD 682.9 million by 2030.
- The Australia market is expected to grow at a CAGR of 7.7% from 2023 to 2030.
- In terms of segment, estrogen and progesterone replacement therapy was the largest revenue generating product in 2022.
- Parathyroid Hormone replacement is the most lucrative product segment registering the fastest growth during the forecast period.
Hormone replacement therapy market data book summary
| Market revenue in 2022 | USD 376.2 million |
| Market revenue in 2030 | USD 682.9 million |
| Growth rate | 7.7% (CAGR from 2022 to 2030) |
| Largest segment | Estrogen and progesterone replacement therapy |
| Fastest growing segment | Parathyroid Hormone replacement |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Estrogen and Progesterone Replacement Therapy, HGH replacement therapy, Thryoid hormone replacement therapy, Testosterone Replacement Therapy, Parathyroid Hormone replacement |
| Key market players worldwide | Eli Lilly and Co, Bayer AG, Hisamitsu Pharmaceutical Co Inc, Pfizer Inc, Merck & Co Inc, Viatris Inc, Novo Nordisk A/S ADR, AbbVie Inc, Roche Holding AG ADR, Ascend Wellness Holdings Inc |
Other key industry trends
- In terms of revenue, Australia accounted for 1.8% of the global hormone replacement therapy market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan hormone replacement therapy market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,698.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hormone Replacement Therapy Market Scope
Hormone Replacement Therapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia hormone replacement therapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hormone replacement therapy market will help companies and investors design strategic landscapes.
Estrogen and progesterone replacement therapy was the largest segment with a revenue share of 53.4% in 2022. Horizon Databook has segmented the Australia hormone replacement therapy market based on estrogen and progesterone replacement therapy, hgh replacement therapy, thryoid hormone replacement therapy, testosterone replacement therapy, parathyroid hormone replacement covering the revenue growth of each sub-segment from 2018 to 2030.
Australia hormone replacement therapy market witnessed significant growth over the forecast period owing to the strong presence of global players & their subsidiaries and key strategies undertaken by them to expand their businesses. Furthermore, supportive regulatory policies and approval of novel hormone replacement therapy drugs are anticipated to fuel market growth.
For instance, in March 2022, Novo Nordisk Pharmaceuticals Pty Ltd., a subsidiary of Novo Nordisk SA, received approval from Australia Therapeutic Goods Administration (TGA) for Sogroya (somapacitan) to treat adults with growth hormone deficiency.
It is a long-acting recombinant human growth hormone derivative, which consists of 191 amino acids, and is administrated subcutaneously to patients. Currently, this product is under the black triangle scheme for 5 years, starting on the date the product is first supplied in the country.
Reasons to subscribe to Australia hormone replacement therapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia hormone replacement therapy market databook
-
Our clientele includes a mix of hormone replacement therapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia hormone replacement therapy market , including forecasts for subscribers. This country databook contains high-level insights into Australia hormone replacement therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia hormone replacement therapy market size, by product, 2018-2030 (US$M)
Australia Hormone Replacement Therapy Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
